{
  "validation_metadata": {
    "description": "CTIS Database Validation Reference Data - EXAMPLE WITH DUMMY DATA",
    "instructions": "This is a fully filled example. Replace with real data from CTIS portal.",
    "date_collected": "2025-01-06",
    "collected_by": "Database Validator",
    "notes": "This contains realistic dummy data for demonstration. Replace all values with actual CTIS data for real validation."
  },
  "trials": [
    {
      "ctNumber": "2023-506843-40-00",
      "ctPublicStatusCode": "Authorised",
      "title": "AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-label randomized study",
      "shortTitle": "ADVANCE-301",
      "sponsor": "Centre Hospitalier Universitaire Amiens Picardie",
      "trialPhase": "Therapeutic confirmatory (Phase III)",
      "therapeuticAreas": "Diseases [C] - Bacterial Infections and Mycoses [C01]",
      "countries": "France;Germany;Spain;Italy;Netherlands;Belgium",
      "decisionDate": "2024-03-15",
      "publishDate": "2024-03-20",
      "lastUpdated": "2024-11-01",
      "sites": {
        "total_count": 45,
        "examples": [
          {
            "site_name": "Institut Gustave Roussy",
            "organisation": "Institut Gustave Roussy",
            "country": "France",
            "city": "Villejuif"
          },
          {
            "site_name": "Charité Universitätsmedizin Berlin",
            "organisation": "Charité - Universitätsmedizin Berlin",
            "country": "Germany",
            "city": "Berlin"
          },
          {
            "site_name": "Hospital Universitario 12 de Octubre",
            "organisation": "Hospital Universitario 12 de Octubre",
            "country": "Spain",
            "city": "Madrid"
          }
        ]
      },
      "people": {
        "total_count": 67,
        "examples": [
          {
            "name": "Dr. Marie Dubois",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Public Contact (Sponsor)",
            "country": "Switzerland"
          },
          {
            "name": "Prof. Hans Schmidt",
            "role": "Site Investigator",
            "country": "Germany"
          }
        ]
      },
      "notes": "Large multi-country Phase III oncology trial with extensive site network"
    },
    {
      "ctNumber": "2024-516849-39-01",
      "ctPublicStatusCode": "Ongoing, recruiting",
      "title": "An Open-Label, Multicenter Study Evaluating the Long-Term Safety and Tolerability of XYZ-123 in Patients with Chronic Condition",
      "shortTitle": "EXTEND-LT",
      "sponsor": "F. Hoffmann-La Roche AG",
      "trialPhase": "Phase IV",
      "therapeuticAreas": "Diseases [C] - Immune System Diseases [C20]",
      "countries": "France;Germany;United Kingdom;Spain;Poland;Italy",
      "decisionDate": "2024-05-22",
      "publishDate": "2024-05-28",
      "lastUpdated": "2024-10-15",
      "sites": {
        "total_count": 78,
        "examples": [
          {
            "site_name": "Assistance Publique - Hôpitaux de Paris",
            "organisation": "AP-HP - Hôpital Saint-Louis",
            "country": "France",
            "city": "Paris"
          },
          {
            "site_name": "University College London Hospitals",
            "organisation": "UCLH NHS Foundation Trust",
            "country": "United Kingdom",
            "city": "London"
          }
        ]
      },
      "people": {
        "total_count": 156,
        "examples": [
          {
            "name": "",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Scientific Contact (Sponsor)",
            "country": "Switzerland"
          }
        ]
      },
      "notes": "Phase IV post-marketing surveillance study with large patient population"
    },
    {
      "ctNumber": "2024-516906-47-00",
      "ctPublicStatusCode": "Authorised",
      "title": "A Phase I/II, First-in-Human, Dose-Escalation and Dose-Expansion Study of Novel Agent ABC-789 in Participants with Advanced Solid Tumors",
      "shortTitle": "FIRST-STEP",
      "sponsor": "AstraZeneca AB",
      "trialPhase": "Phase I/II",
      "therapeuticAreas": "Diseases [C] - Neoplasms [C04]",
      "countries": "France;Spain;United States",
      "decisionDate": "2024-07-10",
      "publishDate": "2024-07-15",
      "lastUpdated": "2024-09-20",
      "sites": {
        "total_count": 12,
        "examples": [
          {
            "site_name": "Institut de Cancérologie de l'Ouest",
            "organisation": "ICO René Gauducheau",
            "country": "France",
            "city": "Saint-Herblain"
          },
          {
            "site_name": "Hospital Universitari Vall d'Hebron",
            "organisation": "Vall d'Hebron University Hospital",
            "country": "Spain",
            "city": "Barcelona"
          }
        ]
      },
      "people": {
        "total_count": 28,
        "examples": [
          {
            "name": "Dr. Jean Martin",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Public Contact (Sponsor)",
            "country": "United Kingdom"
          }
        ]
      },
      "notes": "Early phase dose-finding study with integrated Phase I/II design"
    },
    {
      "ctNumber": "2023-507521-41-01",
      "ctPublicStatusCode": "Ended",
      "title": "A Randomized, Double-Blind, Phase III Study Comparing Standard Treatment Plus Investigational Agent Versus Standard Treatment Alone in Patients with Cardiovascular Disease",
      "shortTitle": "CARDIO-PROTECT",
      "sponsor": "Boehringer Ingelheim International GmbH",
      "trialPhase": "Phase III",
      "therapeuticAreas": "Diseases [C] - Cardiovascular Diseases [C14]",
      "countries": "France;Germany;Spain;Italy;Belgium;Netherlands;Poland;Czechia",
      "decisionDate": "2023-08-30",
      "publishDate": "2023-09-05",
      "lastUpdated": "2024-08-15",
      "sites": {
        "total_count": 123,
        "examples": [
          {
            "site_name": "Centre Hospitalier Universitaire de Toulouse",
            "organisation": "CHU Toulouse - Hôpital Rangueil",
            "country": "France",
            "city": "Toulouse"
          },
          {
            "site_name": "Klinikum der Universität München",
            "organisation": "Ludwig-Maximilians-Universität München",
            "country": "Germany",
            "city": "München"
          },
          {
            "site_name": "Ospedale San Raffaele",
            "organisation": "IRCCS Ospedale San Raffaele",
            "country": "Italy",
            "city": "Milano"
          }
        ]
      },
      "people": {
        "total_count": 245,
        "examples": [
          {
            "name": "Prof. Pierre Dubois",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "Dr. Klaus Müller",
            "role": "Site Investigator",
            "country": "Germany"
          },
          {
            "name": "",
            "role": "Scientific Contact (Sponsor)",
            "country": "Germany"
          }
        ]
      },
      "notes": "Completed Phase III cardiovascular outcomes trial with extensive follow-up"
    },
    {
      "ctNumber": "2023-506558-20-00",
      "ctPublicStatusCode": "Authorised",
      "title": "Expanded Access Program for Emergency Use of Investigational Treatment in Patients with Life-Threatening Condition",
      "shortTitle": "EAP-EMERGENCY",
      "sponsor": "Pfizer Inc.",
      "trialPhase": "Expanded Access",
      "therapeuticAreas": "Diseases [C] - Respiratory Tract Diseases [C08]",
      "countries": "France;Germany;Italy;Spain",
      "decisionDate": "2023-11-20",
      "publishDate": "2023-11-22",
      "lastUpdated": "2024-10-30",
      "sites": {
        "total_count": 34,
        "examples": [
          {
            "site_name": "Hôpital Bichat - Claude Bernard",
            "organisation": "AP-HP - Hôpital Bichat",
            "country": "France",
            "city": "Paris"
          },
          {
            "site_name": "Universitätsklinikum Heidelberg",
            "organisation": "Universitätsklinikum Heidelberg",
            "country": "Germany",
            "city": "Heidelberg"
          }
        ]
      },
      "people": {
        "total_count": 52,
        "examples": [
          {
            "name": "",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Public Contact (Sponsor)",
            "country": "United States"
          }
        ]
      },
      "notes": "Expanded access program providing treatment to patients with serious condition"
    },
    {
      "ctNumber": "2024-510234-28-00",
      "ctPublicStatusCode": "Authorised",
      "title": "A Bioequivalence Study Comparing Two Formulations of Generic Drug in Healthy Volunteers Under Fasting and Fed Conditions",
      "shortTitle": "BE-STUDY-2024",
      "sponsor": "Merck Sharp & Dohme LLC",
      "trialPhase": "Phase I",
      "therapeuticAreas": "Diseases [C] - Nutritional and Metabolic Diseases [C18]",
      "countries": "France",
      "decisionDate": "2024-02-14",
      "publishDate": "2024-02-16",
      "lastUpdated": "2024-08-22",
      "sites": {
        "total_count": 1,
        "examples": [
          {
            "site_name": "Eurofins Optimed Clinical Research",
            "organisation": "Eurofins Optimed",
            "country": "France",
            "city": "Gières"
          }
        ]
      },
      "people": {
        "total_count": 8,
        "examples": [
          {
            "name": "Dr. Laurent Bernard",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Public Contact (Sponsor)",
            "country": "United States"
          }
        ]
      },
      "notes": "Single-site Phase I bioequivalence study in healthy volunteers"
    },
    {
      "ctNumber": "2024-512890-15-00",
      "ctPublicStatusCode": "Ongoing, recruiting",
      "title": "An Observational, Non-Interventional Registry Study to Assess Real-World Outcomes in Patients Receiving Standard of Care Treatment",
      "shortTitle": "REAL-WORLD-REGISTRY",
      "sponsor": "Assistance Publique Hopitaux De Paris",
      "trialPhase": "Non-Interventional",
      "therapeuticAreas": "Diseases [C] - Nervous System Diseases [C10]",
      "countries": "France",
      "decisionDate": "2024-06-05",
      "publishDate": "2024-06-10",
      "lastUpdated": "2024-11-05",
      "sites": {
        "total_count": 28,
        "examples": [
          {
            "site_name": "Hôpital de la Pitié-Salpêtrière",
            "organisation": "AP-HP - Groupe Hospitalier Pitié-Salpêtrière",
            "country": "France",
            "city": "Paris"
          },
          {
            "site_name": "CHU de Bordeaux",
            "organisation": "Centre Hospitalier Universitaire de Bordeaux",
            "country": "France",
            "city": "Bordeaux"
          }
        ]
      },
      "people": {
        "total_count": 42,
        "examples": [
          {
            "name": "Prof. Sophie Laurent",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Scientific Contact (Sponsor)",
            "country": "France"
          }
        ]
      },
      "notes": "Academic non-interventional registry study collecting real-world data"
    },
    {
      "ctNumber": "2023-503456-89-00",
      "ctPublicStatusCode": "Authorised",
      "title": "Compassionate Use Program for Individual Patient Access to Investigational Medicinal Product for Rare Disease",
      "shortTitle": "CU-RARE-2023",
      "sponsor": "Novartis Pharma AG",
      "trialPhase": "Compassionate Use",
      "therapeuticAreas": "Diseases [C] - Hemic and Lymphatic Diseases [C15]",
      "countries": "France;Germany;Spain",
      "decisionDate": "2023-12-10",
      "publishDate": "2023-12-12",
      "lastUpdated": "2024-09-18",
      "sites": {
        "total_count": 8,
        "examples": [
          {
            "site_name": "Hôpital Necker-Enfants Malades",
            "organisation": "AP-HP - Hôpital Necker",
            "country": "France",
            "city": "Paris"
          },
          {
            "site_name": "Hospital Universitario La Paz",
            "organisation": "Hospital La Paz",
            "country": "Spain",
            "city": "Madrid"
          }
        ]
      },
      "people": {
        "total_count": 15,
        "examples": [
          {
            "name": "Dr. Marie Lambert",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Public Contact (Sponsor)",
            "country": "Switzerland"
          }
        ]
      },
      "notes": "Compassionate use program for individual patient access to rare disease treatment"
    },
    {
      "ctNumber": "2024-514567-33-00",
      "ctPublicStatusCode": "Authorised",
      "title": "A Phase II/III, Randomized, Open-Label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Novel Therapy in Participants with Advanced Disease",
      "shortTitle": "BREAKTHROUGH-203",
      "sponsor": "Eli Lilly & Co.",
      "trialPhase": "Phase II/III",
      "therapeuticAreas": "Diseases [C] - Neoplasms [C04]",
      "countries": "France;Germany;United Kingdom;Spain;Italy;Belgium",
      "decisionDate": "2024-04-18",
      "publishDate": "2024-04-25",
      "lastUpdated": "2024-10-28",
      "sites": {
        "total_count": 56,
        "examples": [
          {
            "site_name": "Centre Léon Bérard",
            "organisation": "Centre Léon Bérard",
            "country": "France",
            "city": "Lyon"
          },
          {
            "site_name": "Royal Marsden Hospital",
            "organisation": "The Royal Marsden NHS Foundation Trust",
            "country": "United Kingdom",
            "city": "London"
          }
        ]
      },
      "people": {
        "total_count": 89,
        "examples": [
          {
            "name": "Dr. Catherine Moreau",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "",
            "role": "Scientific Contact (Sponsor)",
            "country": "United States"
          }
        ]
      },
      "notes": "Integrated Phase II/III seamless design in advanced oncology indication"
    },
    {
      "ctNumber": "2024-518901-42-00",
      "ctPublicStatusCode": "Authorised",
      "title": "A Phase III/IV Post-Authorization Safety Study to Monitor Long-Term Safety of Approved Treatment in Extended Patient Population",
      "shortTitle": "PASS-LONGTERM",
      "sponsor": "AbbVie Deutschland GmbH & Co. KG",
      "trialPhase": "Phase III/IV",
      "therapeuticAreas": "Diseases [C] - Digestive System Diseases [C06]",
      "countries": "France;Germany;Spain;Italy;Netherlands;Belgium;Poland;Austria",
      "decisionDate": "2024-08-12",
      "publishDate": "2024-08-18",
      "lastUpdated": "2024-11-02",
      "sites": {
        "total_count": 95,
        "examples": [
          {
            "site_name": "Hôpital Beaujon",
            "organisation": "AP-HP - Hôpital Beaujon",
            "country": "France",
            "city": "Clichy"
          },
          {
            "site_name": "Universitätsklinikum Frankfurt",
            "organisation": "Goethe-Universität Frankfurt",
            "country": "Germany",
            "city": "Frankfurt am Main"
          },
          {
            "site_name": "Erasmus MC",
            "organisation": "Erasmus University Medical Center Rotterdam",
            "country": "Netherlands",
            "city": "Rotterdam"
          }
        ]
      },
      "people": {
        "total_count": 178,
        "examples": [
          {
            "name": "Prof. Jean Dupont",
            "role": "Site Investigator",
            "country": "France"
          },
          {
            "name": "Dr. Hans Weber",
            "role": "Site Investigator",
            "country": "Germany"
          },
          {
            "name": "",
            "role": "Public Contact (Sponsor)",
            "country": "Germany"
          }
        ]
      },
      "notes": "Large post-authorization safety study bridging Phase III and IV with extensive site network"
    }
  ]
}